Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64 | 3 | 341 | 5 | N/A |
| TOTAL | $158 | $7 | $440 | $5 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 117,807 | 0 | 0 |
| Intangibles | 2,300 | 2,186 | 0 | 0 | 0 |
| TOTAL | $2,300 | $2,186 | $117,807 | $N/A | $N/A |
| Total Assets | $2,457 | $2,193 | $118,247 | $5 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 64 | 151 | 0 | 9 | 0 |
| Accrued Expenses | 912 | 3 | 140 | N/A | N/A |
| TOTAL | $1,248 | $1,621 | $506 | $9 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25 | 0 | 121,706 | 0 | 0 |
| TOTAL | $25 | $N/A | $121,785 | $N/A | $N/A |
| Total Liabilities | $1,272 | $1,621 | $122,291 | $9 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,511 | 1,760 | 8,802 | N/A | N/A |
| Common Shares | 3 | 2 | 0 | N/A | N/A |
| Retained earnings | -10,563 | -3,924 | -4,045 | -4 | N/A |
| TOTAL | $1,185 | $572 | $-4,045 | $-4 | $N/A |
| Total Liabilities And Equity | $2,457 | $2,193 | $118,247 | $5 | $0 |